Non-perturbative delivery effectively enables us to transport more cargo types into a variety of primary cell types with higher cell viability and tighter dosage distributions than traditional transfection methods.
By overcoming the cell viability and manufacturing challenges plaguing vector-based cell and gene therapy development, NAVAN is actively developing therapies in a broad range of indications with strategic partnerships in place.
NanoStraws are a physical, non-perturbative conduit for delivery, or “pipelines” into and out of cells. These conduits provide some of the highest efficiencies, widest range of cell types, and variety of cargos available. Facile cellular access is changing how we think about cell manipulation and therapy development while dramatically reducing the challenges of viral-based cell manufacturing.